A rapid, semi-quantitative assay to screen for modulators of alpha-synuclein oligomerization ex vivo

A rapid, semi-quantitative assay to screen for modulators of alpha-synuclein oligomerization ex vivo

Alpha synuclein (αsyn) aggregates are associated with the pathogenesis of Parkinson’s disease and others related disorders. Although modulation of αsyn aggregation is an attractive therapeutic target, new powerful methodologies are desperately needed to facilitate in vivo screening of novel therapeu...

Full description

Bibliographic Details
Main Authors:	Marion eDelenclos, Teodora eTrendafilova, Daryl R Jones, Simon eMoussaud, Ann Marie eBaine, Mei eYue, Warren D Hirst, Pamela J McLean
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-01-01
Series:	Frontiers in Neuroscience
Subjects:	alpha-Synuclein oligomers bioluminescence protein-fragment complementation viral vector model
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnins.2015.00511/full

Similar Items

Exosomal cell-to-cell transmission of alpha synuclein oligomers
by: Danzer Karin M, et al.
Published: (2012-08-01)

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
by: Ilham Y. Abdi, et al.
Published: (2021-03-01)

Oligomerization by co-assembly of β-amyloid and α-synuclein
by: Jin Ryoun Kim
Published: (2023-03-01)

Acetylated α-Tubulin and α-Synuclein: Physiological Interplay and Contribution to α-Synuclein Oligomerization
by: Alessandra Maria Calogero, et al.
Published: (2023-07-01)

Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
by: Hazel L. Roberts, et al.
Published: (2015-03-01)

Targeting heat shock proteins to modulate α-synuclein toxicity
by: Daryl Rhys Jones, et al.
Published: (2014-01-01)

Implementing Complementary Approaches to Shape the Mechanism of α-Synuclein Oligomerization as a Model of Amyloid Aggregation
by: Marco Giampà, et al.
Published: (2021-12-01)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
by: Xiao-yu Du, et al.
Published: (2020-11-01)

Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum
by: Fabiana Miraglia, et al.
Published: (2020-08-01)

The Role of Lipids in the Initiation of α-Synuclein Misfolding
by: Martin Kiechle, et al.
Published: (2020-09-01)

Characterization of α-synuclein oligomers formed in the presence of lipid vesicles
by: Anvesh K.R. Dasari, et al.
Published: (2024-07-01)

Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway
by: Jae-Hyeon Park, et al.
Published: (2020-01-01)

Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain
by: Marion Delenclos, et al.
Published: (2017-06-01)

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers
by: Nishant Vaikath, et al.
Published: (2022-11-01)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
by: Carroll Rutherford Fields, et al.
Published: (2019-12-01)

Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
by: Cecilia Chavarría, et al.
Published: (2022-04-01)

Reduction of brain stem pathology and transient amelioration of early cognitive symptoms in transgenic mice treated with a monoclonal antibody against α-synuclein oligomers/protofibrils
by: S. Ekmark-Lewén, et al.
Published: (2023-01-01)

CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriers
by: Nour K. Majbour, et al.
Published: (2020-05-01)

Polymorphism in alpha-synuclein oligomers and its implications in toxicity under disease conditions
by: Je Min Yoo, et al.
Published: (2022-08-01)

Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons
by: Emanuela Colla, et al.
Published: (2018-03-01)

How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology
by: Senthil T. Kumar, et al.
Published: (2020-12-01)

Initiation and propagation of α-synuclein aggregation in the nervous system
by: Baraa A. Hijaz, et al.
Published: (2020-03-01)

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease
by: Hiroaki Sekiya, et al.
Published: (2022-09-01)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
by: Upasana Ganguly, et al.
Published: (2021-07-01)

Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease
by: Pablo Gracia, et al.
Published: (2020-10-01)

Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes
by: Gabriel Gustafsson, et al.
Published: (2017-12-01)

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein
by: Ebrima Gibbs, et al.
Published: (2022-09-01)

Honokiol decreases alpha-synuclein mRNA levels and reveals novel targets for modulating alpha-synuclein expression
by: Sara J. Fagen, et al.
Published: (2023-08-01)

A novel assay that characterizes properdin function shows neutrophil-derived properdin has a distinct oligomeric distribution
by: Sara R. Moore, et al.
Published: (2023-01-01)

Alpha Synuclein: Neurodegeneration and Inflammation
by: Gianluigi Forloni
Published: (2023-03-01)

The Stimulatory Effects of Intracellular α-Synuclein on Synaptic Transmission Are Attenuated by 2-Octahydroisoquinolin-2(1H)-ylethanamine
by: Alejandra E. Ramirez, et al.
Published: (2021-12-01)

Formation of toxic oligomeric alpha-synuclein species in living cells.
by: Tiago Fleming Outeiro, et al.
Published: (2008-04-01)

Alpha-synuclein oligomers - neurotoxic molecules in Parkinson’s disease and other Lewy body disorders
by: Martin Ingelsson
Published: (2016-09-01)

Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
by: Richard M. Meade, et al.
Published: (2019-07-01)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
by: Laura Boi, et al.
Published: (2020-11-01)

Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
by: Waijiao Cai, et al.
Published: (2018-03-01)

Correction: Formation of Toxic Oligomeric α-Synuclein Species in Living Cells.
by: Tiago Fleming Outeiro, et al.
Published: (2008-01-01)

Nasal Rifampicin Improves Cognition in a Mouse Model of Dementia with Lewy Bodies by Reducing α-Synuclein Oligomers
by: Tomohiro Umeda, et al.
Published: (2021-08-01)

Microtubule depolymerization potentiates alpha-synuclein oligomerization
by: Russell H Swerdlow, et al.
Published: (2010-01-01)